New gene test may help identify prostate cancer:
This article was originally published in Clinica
Executive Summary
A new gene test could help doctors to detect prostate cancer more reliably from tissue samples, according to US researchers at the University of Michigan Medical School. The gene, called AMACR, was reported to be over-expressed in prostate cancer samples and may be a useful diagnostic biomarker in difficult-to-diagnose samples. Study leader, Mark Rubin, reported the gene test to be 97% sensitive and 100% specific for the disease. The findings are published in the Journal of the American Medical Association (April 3).